Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

5

Revenue 2017

Merck & Co.

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck & Co.'s 2013 sales performance.

Merck

NHS England sees off AbbVie's Hep C legal challenge

NHS England sees off AbbVie's Hep C legal challenge

CAR-T therapy (Gilead/Kite’s Yescarta and Novartis’ Kymriah) and a deal to make the MSD’s groundbreaking Keytruda available for routine use for lung cancer patients on the NHS.

HTA guidance from NICE, the SMC and the AWMSG

NICE has, however, only given the green light to MSD's drug via the Cancer Drugs Fund (CDF), as there isn’t enough evidence yet for routine NHS use. ... To discuss how we can support your guidance or implementation needs please contact

Sarah Matthew named as new Hanover Health Chair

Sarah Matthew named as new Hanover Health Chair Sarah Matthew co-founded Virgo Health in 2003, which grew into one of the leading international healthcare communication agencies.

Evenity back on track with FDA panel blessing in osteoporosis

Evenity back on track with FDA panel blessing in osteoporosis It works in a very different way to existing drugs like bisphosphonate alendronate – sold by Merck/MSD as Fosamax – which works only by blocking bone destruction. ... Amgen and UCB are co-developing Evenity worldwide, with development in Japan being

China approves Ironwood Pharma’s IBS treatment

China approves Ironwood Pharma’s IBS treatment The company to be named Ironwood will retain its three marketed gastrointestinal therapies (including Linzess), while the other company will be called Cyclerion (. R&D Co) and will be led by.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics